| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | EP0683781B1 Novel inhibitors of adenosine monophosphate deaminase |
| 04/21/2004 | CN1491227A Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine A3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491125A Use of flumazenil to produce medicament for treatment of cocaine dependency |
| 04/21/2004 | CN1491111A Antiviral method of use |
| 04/21/2004 | CN1146568C Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
| 04/21/2004 | CN1146560C Substituted benzoylpyrazoles as herbicides |
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/20/2004 | US6723798 Combinatorial chemistry; hydroxyphenylalkyl vinyl ether linking group to divinylbenzene-styrene polymer |
| 04/20/2004 | US6723721 CRF receptor antagonists and methods relating thereto |
| 04/20/2004 | US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents |
| 04/16/2004 | CA2443585A1 New derivatives of (3,4-a:3,4-c) carbazole, their preparation process, and pharmaceutical compositions that contain them |
| 04/15/2004 | WO2004031384A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | WO2004031182A1 Piperazine derivatives and methods of use |
| 04/15/2004 | WO2004031150A1 Oxoammonium salts of 1-oxy-2,2,6,6-tetramethyl-1-piperidine (tempo) and their use as oxidizing agents |
| 04/15/2004 | WO2004030635A2 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | WO2004020417A8 2,4-diaminoquinazoline, 2-amino-4-hydroxypteridine and 2,4-diaminopyrimidine ester derivatives as dihydrofolate reductase inhibitors |
| 04/15/2004 | WO2004018477A3 Liquid crystal display and colour filter with improved transparency for green light |
| 04/15/2004 | WO2004006836A3 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 04/15/2004 | WO2004005289A3 Efficient synthesis of pyropheophorbide a and its derivatives |
| 04/15/2004 | WO2003056899A9 Nitric oxide donors for treatment of disease and injury |
| 04/15/2004 | WO2002100354B1 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 04/15/2004 | US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups |
| 04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
| 04/15/2004 | US20040072847 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 04/15/2004 | US20040072835 Anticancer agents; antiinflammatory agents; antiarthritic agents; Alzheimer's diseases; cardiovascular disorders; fungicides |
| 04/15/2004 | US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072831 Reverse-turn mimetics and method relating thereto |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |
| 04/15/2004 | US20040072788 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/15/2004 | US20040072737 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents |
| 04/15/2004 | DE19906975B4 Arzneiform zur Behandlung von Alzheimer'scher Demenz Dosage form for the treatment of Alzheimer's dementia |
| 04/15/2004 | DE10195974T5 Neue substituierte Calix-(4)-Pyrrole und Verfahren für die Synthese der Calix-(4)-Pyrrole über Molekularsiebkatalysatoren New substituted calix (4) pyrroles and procedures for the synthesis of calix (4) pyrroles over molecular sieve catalysts |
| 04/15/2004 | CA2500883A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | CA2500727A1 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | CA2499732A1 Piperazine derivatives and methods of use |
| 04/14/2004 | EP1408041A1 Process for preparation of amidine derivatives |
| 04/14/2004 | EP1408040A1 Tricyclic fused heterocyclic compounds as CRFantagonists |
| 04/14/2004 | EP1406914A2 Porphyrin derivatives for photodynamic therapy |
| 04/14/2004 | EP1406906A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 04/14/2004 | EP1406905A1 Water- and organic-soluble cucurbituril derivatives, their preparation methods, their separation methods and uses |
| 04/14/2004 | EP1406904A1 Method for selectively synthesising triethylenediamine |
| 04/14/2004 | EP1406903A2 Fungicidal triazolopyrimidines, method for the production thereof and use thereof in controlling noxious fungi and agents containing said compounds |
| 04/14/2004 | EP1406902A1 Hexahydroazepino(4,5-g)indoles and indolines as 5-ht receptor ligands |
| 04/14/2004 | EP1406900A1 Novel compounds, their preparation and use |
| 04/14/2004 | EP1406884A1 Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders |
| 04/14/2004 | EP1406871A2 Process for the production of n- 3-(3-cyanopyrazolo 1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon) |
| 04/14/2004 | EP1406632A2 Substituted 3-aryl-5-aryl- 1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/14/2004 | EP1406616A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 04/14/2004 | EP1380295A9 Photosensitiser and method for production thereof |
| 04/14/2004 | EP1202994B1 New compounds |
| 04/14/2004 | EP1189906B1 Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production |
| 04/14/2004 | EP1042315B1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 04/14/2004 | CN1489592A 3,7-diazabicyclo[3,3,o] otanes and their use in treatment of cardiac arrhythmias |
| 04/14/2004 | CN1489591A Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 04/14/2004 | CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489560A Production of fluorine compounds |
| 04/14/2004 | CN1489467A Pharmacentical formulation comprising pyrazolo[4,3-d] pyrimdine and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/14/2004 | CN1145678C Substd. phthalocyanines and their preparation process |
| 04/14/2004 | CN1145627C Pyrazolo [4,3-d] pyrimidines |
| 04/14/2004 | CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof |
| 04/13/2004 | US6720573 Electronic device comprising organic compound having p-type semiconducting characteristics |
| 04/13/2004 | US6720342 Azabicyclic compounds used in treating a disease in the central nervous system caused by malfunctioning of the muscarinic cholinergic system. |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | US6720317 Inhibitors of factor Xa |
| 04/13/2004 | US6720188 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample |
| 04/13/2004 | US6720093 Device incorporating as, or in, its light-emitting element luminescent compound including conjugated dendritic molecular structure comprising groups selected from aryl and heteroaryl groups and alkenyl groups connected to each other |
| 04/13/2004 | CA2141456C A process for the preparation of (-)-eserethole from mixtures of (-) and (+)-eserethole |
| 04/08/2004 | WO2004029579A2 Fluorescent labeling reagents with multiple donors and acceptors |
| 04/08/2004 | WO2004029578A2 Energy transfer dyes, terminators and use thereof |
| 04/08/2004 | WO2004029204A2 Substituted pyrimidines |
| 04/08/2004 | WO2004029058A1 Medicinal composition for inhibiting increase in blood gastrin concentration |
| 04/08/2004 | WO2004029057A1 Medicinal composition for treatment for or prevention of visceral pain |
| 04/08/2004 | WO2004029056A1 [1,2,4]-TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVE |
| 04/08/2004 | WO2004029055A1 Fused azole-pyrimidine derivatives |
| 04/08/2004 | WO2004029051A1 Pyrazole amides for treating hiv infections |
| 04/08/2004 | WO2004029043A1 Pyrazole compounds |
| 04/08/2004 | WO2004029040A1 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases |
| 04/08/2004 | WO2004017961A3 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003093269A3 Substituted pyrazolo-pyrimidine-4-ones |
| 04/08/2004 | WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/08/2004 | WO2003057667B1 Strapped and modified bis (benzimidazole) diamides for asymmetric catalysts and other applications |
| 04/08/2004 | WO2003003806A3 Dye-azide compounds for dual phototherapy |
| 04/08/2004 | US20040068115 Charge transport compositions and electronic devices made with such compositions |
| 04/08/2004 | US20040068007 Diclofenac salt of lidocaine |
| 04/08/2004 | US20040067994 Grampositive, gramnegative bacteria therapy |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/08/2004 | US20040067974 Alzheimer's disease; Down's syndrome; synergistic mixture containing galanthamine |
| 04/08/2004 | US20040067965 Viricides; cytomegalo virus |
| 04/08/2004 | US20040067964 Antiinflammatory agents |
| 04/08/2004 | US20040067951 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof |
| 04/08/2004 | US20040067948 Alzheimer's disease; central nervous system disorders; psychological disorders |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067945 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/08/2004 | US20040067932 Synergistic mixture; anticancer agents; therapy for skin cancer |